Becton Dickinson & Company
Becton Dickinson and Co, formerly Becton Dickinson & Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company' s operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. On February 9, 2012, the Company acquired a 100% interest in KIESTRA Lab Automation BV. On August 24, 2012, the Company acquired a 100% interest in Sirigen Group Limited. On October 31, 2012, the Company sold its BD Biosciences -Discovery Labware unit. In December 2012, the Company acquired Safety Syringes, Inc. Effective March 12, 2013, the Company acquired Cato Software Solutions GmbH.
Profit margin stands at 8.0%.
Current Price
$154.51
-1.17%GoodMoat Value
$146.37
5.3% overvaluedBecton Dickinson & Company (BDX) DCF Calculator
What is a DCF Calculator?
A Discounted Cash Flow (DCF) model estimates a company's intrinsic value by projecting its future cash flows and discounting them back to the present. The core idea: a dollar earned in the future is worth less than a dollar today.
Inputs
Cash flow, discount rate, terminal growth & projection years
Model
Projects cash flows forward, adds terminal value, discounts back
Output
Intrinsic value per share — compare with price for margin of safety
Ready to Calculate
Enter a ticker on the left to auto-fill real financial data and get started.
BDX DCF Calculator — Discounted Cash Flow
Discounted Cash Flow (DCF) calculator for Becton Dickinson & Company (BDX). Estimate the intrinsic value of BDX stock by projecting future cash flows and discounting them to present value. The two-stage DCF model supports EPS-based, FCF-based, and dividend-based approaches.
Current EPS: $5.82. Free cash flow: $2.67B. FCF growth rate: 1.98%. WACC: 10.00%. Shares outstanding: 285.4M. GoodMoat fair value: $146.37.
The DCF calculator projects 10 years of cash flows at a user-adjustable growth rate, applies a terminal growth rate, and discounts all future cash flows back to present value using the weighted average cost of capital (WACC). A sensitivity table shows how the intrinsic value changes across different growth and discount rate assumptions. Use this tool alongside GoodMoat's reverse DCF and fair value models to triangulateBecton Dickinson & Company's true worth.